MiR-142-3p targets HMGA2 and suppresses breast cancer malignancy
Behzad Mansoori(Tabriz University of Medical Sciences), Behzad Baradaran(Tabriz University of Medical Sciences)
Cited by 52
Related Papers
The current landscape of CAR T-cell therapy for solid tumors: Mechanisms, research progress, challenges, and counterstrategies
|Frontiers in Immunology|2023|192
Novel CAR T therapy is a ray of hope in the treatment of seriously ill AML patients
|Stem Cell Research & Therapy|2021|132
CAR-engineered NK cells; a promising therapeutic option for treatment of hematological malignancies
|Stem Cell Research & Therapy|2021|76
The role of miR‐34 in cancer drug resistance
|Journal of Cellular Physiology|2020|34
HMGA2 Supports Cancer Hallmarks in Triple-Negative Breast Cancer
|Cancers|2021|34